Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044793 · ClinicalTrials.gov registry record
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
A clinical trial of Glaucoma Open-Angle, sponsored by Sight Sciences.
- Completed
- Registry status
- 70
- Enrollment target
- 4
- Study locations
NCT05044793 is a study of Glaucoma Open-Angle that has completed, run by Sight Sciences. The registered enrollment target is 70 participants, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (57% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT05044793, a study of Glaucoma Open-Angle, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213
Conditions Studied
Interventions
- DEVICE OMNI® Surgical System
Study Locations (4)
Kansas
- Grene Vision Group - Wichita
Oklahoma
- Oklahoma Eye Surgeons - Oklahoma City
Pennsylvania
- Northern Ophthalmics - Jenkintown
Texas
- El Paso Eye Surgeons - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2023-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05044793
The ClinicalTrials.gov registry entry for NCT05044793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (57% lower). The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 1 intervention - of which OMNI® Surgical System is the first listed.
NCT05044793 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kansas, Oklahoma, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05044793 about?
NCT05044793 is a clinical study titled "A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System". The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213
What is the current status of trial NCT05044793?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2021-09-01. Estimated completion is 2023-08-21.
What conditions does trial NCT05044793 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT05044793?
The interventions under investigation include: OMNI® Surgical System (DEVICE).
Who is sponsoring clinical trial NCT05044793?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05044793 being conducted?
This trial has 4 study locations across Kansas, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
RECRUITING · Phase 3
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Optic Nerve Head Strain as Biomarker for Glaucoma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.